SCHEMBL24427240

SCHEMBL24427240

Cc1ncc(-c2ccc(N)c(OC(F)(F)F)c2)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN10A Q9Y5Y9 10/20 0.44
▸ KCNH2 Q12809 6/20 0.44
▸ SCN1A P35498 2/20 0.44
▸ SCN5A Q14524 2/20 0.44
▸ SCN9A Q15858 2/20 0.44
▸ SCN2A Q99250 2/20 0.44
▸ SCN8A Q9UQD0 2/20 0.44
▸ CYP2A6 P11509 1/20 0.39
▸ NPY5R Q15761 2/20 0.38
▸ BACE1 P56817 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24427241 0.80 CYP2A6 (0.43) SCN10AKCNH2SCN1ASCN5ASCN9A
SCHEMBL6927527 0.75 ALDH1A1 (0.54) SCN5ASCN9AALDH1A1HSD17B10KDM4E
SCHEMBL24428023 0.75 CREBBP (0.37) ALDH1A1HSD17B10KDM4EMEN1POLB
SCHEMBL10273623 0.70 ABL1 (0.48) ALDH1A1HSD17B10CYP3A4TSHRTDP1
SCHEMBL7789671 0.70 TDP1 (0.47) SCN5AALDH1A1HSD17B10KDM4EMEN1
SCHEMBL24427383 0.69 CYP2A6 (0.41) CYP2A6MAPTL3MBTL1
SCHEMBL24427567 0.69 CYP2A6 (0.53) SCN10ASCN2ACYP2A6NPY5RALDH1A1
SCHEMBL3673207 0.69 CYP3A4 (0.46) ALDH1A1HSD17B10MAPTMAPK1KMT2A
SCHEMBL4439767 0.69 AAK1 (0.49) ALDH1A1HSD17B10KDM4EMEN1POLB
SCHEMBL15507790 0.69 PDE3B (0.48) KCNH2CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518766-B2 Tricyclic compound, preparation method therefor and use thereof SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD. (CN) 2022-12-06 — — US disclosed
EP-3998263-A1 TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) 2022-05-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11518766-B2 Tricyclic compound, preparation method therefor and use thereof TFPI, TFPI2, F11 SCN10A 1157/4885KCNH2 2686/4885SCN1A 881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback